Systemic lupus erythematosus diagnostics in the 'omics' era

Area of Science:

• Immunology and Autoimmune Diseases
• Genomics and Molecular Biology

Background:

• Systemic lupus erythematosus (SLE) is a complex autoimmune disease impacting multiple organ systems.
• Current diagnosis relies on the American College of Rheumatology (ACR) criteria, requiring at least four out of eleven criteria.
• There is a need for novel diagnostics to identify susceptible individuals in early disease stages.

Purpose of the Study:

• To investigate the potential of multi-omics platforms for discovering novel biomarkers in SLE.
• To enhance the early identification and sensitive tracking of SLE disease course.

Main Methods:

• Utilizing comprehensive 'omics' platforms including genomics, transcriptomics, proteomics, and metabolomics.
• Analyzing biological data at multiple molecular levels to re-examine SLE.
• Focusing on the discovery of new biomarkers for SLE.

Main Results:

• 'Omics' platforms provide a high molecular resolution for studying SLE.
• These platforms hold promise for identifying novel biomarkers.
• Potential for improved sensitivity and specificity in tracking SLE disease progression.

Conclusions:

• Multi-omics approaches offer a powerful strategy for understanding SLE at a molecular level.
• The discovery of novel biomarkers through these platforms could revolutionize SLE diagnosis and management.
• Future research using 'omics' may lead to more accurate and sensitive clinical tools for SLE.